CZ297354B6 - Prípravek pro aplikaci v ústní dutine s filmem nebo fólií s okamzitou smácitelností - Google Patents
Prípravek pro aplikaci v ústní dutine s filmem nebo fólií s okamzitou smácitelností Download PDFInfo
- Publication number
- CZ297354B6 CZ297354B6 CZ0164799A CZ164799A CZ297354B6 CZ 297354 B6 CZ297354 B6 CZ 297354B6 CZ 0164799 A CZ0164799 A CZ 0164799A CZ 164799 A CZ164799 A CZ 164799A CZ 297354 B6 CZ297354 B6 CZ 297354B6
- Authority
- CZ
- Czechia
- Prior art keywords
- film
- composition according
- ethoxy
- poly
- mixture
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title description 13
- 239000000203 mixture Substances 0.000 claims abstract description 37
- -1 sorbitan ester Chemical class 0.000 claims abstract description 26
- 239000013543 active substance Substances 0.000 claims abstract description 18
- 210000000214 mouth Anatomy 0.000 claims abstract description 17
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 11
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 8
- 239000000194 fatty acid Substances 0.000 claims abstract description 8
- 229930195729 fatty acid Natural products 0.000 claims abstract description 8
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims abstract description 7
- 229920001400 block copolymer Polymers 0.000 claims abstract description 6
- 239000004359 castor oil Substances 0.000 claims abstract description 6
- 235000019438 castor oil Nutrition 0.000 claims abstract description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 125000003118 aryl group Chemical group 0.000 claims abstract description 3
- 239000008240 homogeneous mixture Substances 0.000 claims abstract description 3
- 239000003795 chemical substances by application Substances 0.000 claims abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 9
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical group OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 5
- 239000002736 nonionic surfactant Substances 0.000 claims description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 230000000954 anitussive effect Effects 0.000 claims description 4
- 239000003434 antitussive agent Substances 0.000 claims description 4
- 229940124584 antitussives Drugs 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 239000003172 expectorant agent Substances 0.000 claims description 4
- 230000003419 expectorant effect Effects 0.000 claims description 4
- 229940066493 expectorants Drugs 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 239000008376 breath freshener Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 229940041616 menthol Drugs 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 2
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 241000416162 Astragalus gummifer Species 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 229920001615 Tragacanth Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000003266 anti-allergic effect Effects 0.000 claims description 2
- 230000003556 anti-epileptic effect Effects 0.000 claims description 2
- 230000002921 anti-spasmodic effect Effects 0.000 claims description 2
- 239000000043 antiallergic agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000001961 anticonvulsive agent Substances 0.000 claims description 2
- 229960003965 antiepileptics Drugs 0.000 claims description 2
- 239000000739 antihistaminic agent Substances 0.000 claims description 2
- 229940125715 antihistaminic agent Drugs 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 229940124575 antispasmodic agent Drugs 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000000496 cardiotonic agent Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000003326 hypnotic agent Substances 0.000 claims description 2
- 230000000147 hypnotic effect Effects 0.000 claims description 2
- 210000004877 mucosa Anatomy 0.000 claims description 2
- 239000004081 narcotic agent Substances 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 229940125723 sedative agent Drugs 0.000 claims description 2
- 239000000932 sedative agent Substances 0.000 claims description 2
- 235000010413 sodium alginate Nutrition 0.000 claims description 2
- 239000000661 sodium alginate Substances 0.000 claims description 2
- 229940005550 sodium alginate Drugs 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000003416 antiarrhythmic agent Substances 0.000 claims 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims 1
- 230000003178 anti-diabetic effect Effects 0.000 claims 1
- 239000003163 gonadal steroid hormone Substances 0.000 claims 1
- 239000000842 neuromuscular blocking agent Substances 0.000 claims 1
- 239000005495 thyroid hormone Substances 0.000 claims 1
- 229940036555 thyroid hormone Drugs 0.000 claims 1
- 239000010410 layer Substances 0.000 abstract description 9
- 210000004400 mucous membrane Anatomy 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 239000012790 adhesive layer Substances 0.000 abstract description 2
- 239000011149 active material Substances 0.000 abstract 2
- 239000002313 adhesive film Substances 0.000 abstract 1
- 150000005215 alkyl ethers Chemical class 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000010408 film Substances 0.000 description 45
- 229920000642 polymer Polymers 0.000 description 12
- 238000003756 stirring Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000004698 Polyethylene Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 210000002200 mouth mucosa Anatomy 0.000 description 5
- 230000003232 mucoadhesive effect Effects 0.000 description 5
- 108010011485 Aspartame Proteins 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000605 aspartame Substances 0.000 description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 4
- 229960003438 aspartame Drugs 0.000 description 4
- 235000010357 aspartame Nutrition 0.000 description 4
- 239000012876 carrier material Substances 0.000 description 4
- 239000002655 kraft paper Substances 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 3
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 229930040373 Paraformaldehyde Natural products 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000008368 mint flavor Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920006324 polyoxymethylene Polymers 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000001593 sorbitan monooleate Substances 0.000 description 3
- 235000011069 sorbitan monooleate Nutrition 0.000 description 3
- 229940035049 sorbitan monooleate Drugs 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- 239000004097 EU approved flavor enhancer Substances 0.000 description 2
- 235000014766 Mentha X piperi var citrata Nutrition 0.000 description 2
- 244000007703 Mentha citrata Species 0.000 description 2
- 235000007421 Mentha citrata Nutrition 0.000 description 2
- 235000008660 Mentha x piperita subsp citrata Nutrition 0.000 description 2
- 235000002431 Monarda citriodora Nutrition 0.000 description 2
- 229920003081 Povidone K 30 Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 235000019264 food flavour enhancer Nutrition 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229950008882 polysorbate Drugs 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- AIBWPBUAKCMKNS-PPHPATTJSA-N 2-hydroxybenzoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C1=CC=CC=C1O.CN1CCC[C@H]1C1=CC=CN=C1 AIBWPBUAKCMKNS-PPHPATTJSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000007967 peppermint flavor Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229940044476 poloxamer 407 Drugs 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/90—Block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- General Preparation And Processing Of Foods (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Dental Preparations (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Prípravek pro aplikaci v ústní dutine s vrstvou nebo filmem pevne ulpívající(m) na sliznici, kde pevne ulpívající vrstva nebo pevne ulpívající film obsahuje homogenní smes sestávající z vodorozpustného polymeru, smesi neionogenních povrchove aktivních látek, polyalkoholu, kosmeticky nebo farmaceuticky úcinné látky a ochucovací nebo aromatické látky. Smes neionogenních povrchove aktivních látek sestává ze dvou slozek, pricemz první slozkou je polyethoxysorbitanový ester mastné kyseliny nebo blokový kopolymer .alfa.-hydro-.omega.-hydroxypoly(ethoxy)-poly-(propoxy)-poly(ethoxy) a druhou slozkou je polyethoxyalkylether nebo polyethoxyderivát ricinového oleje, pricemz pomer mezi první a druhou slozkou binární povrchove aktivní smesi je udrzovánmezi 1:10 a 1:1.
Description
Přípravek pro aplikaci v ústní dutině s filmem nebo fólií s okamžitou smáčitelností
Oblast techniky
Předložený vynález se týká přípravku, který obsahuje farmaceuticky účinné látky a/nebo dech osvěžující látky pro použití v ústní dutině. Nosič obsahuje ve vodě rozpustné polymery obsahující kombinaci určitých látek a má terapeutický a/nebo kosmetický účinek. Film se natírá za použití běžných technologií pro nanášení, vysuší se a vykazuje okamžitou smáčitelnost, následovanou rychlým rozpuštěním/rozkladem při aplikaci v ústní dutině.
Dosavadní stav techniky
Podle dosavadního stavu techniky jsou známy na sliznici ulpívající (mukoadhesivní) dávkovači systémy do ústní dutiny, pomocí nichž mají být dávkovány terapeuticky a/nebo kosmeticky účinné látky na ústní sliznici. Patent US 5 047 224 popisuje na ústní sliznici ulpívající nosič pro kontrolované dávkování terapeuticky účinné látky do tkáně sliznice, který obsahuje bezvodou, ale hydratizovatelnou polymemí matrici a amorfní oxid křemičitý. Může být případně připojen ve vodě nerozpustný film, aby se vytvořil neadhesivní povrch. Mezinárodní patentová přihláška WO 91/06 270 od stejného původce publikuje třívrstvý film k prodlouženému dávkování aktivní účinné látky v ústní dutině. Stejným způsobem uvádí patent US 4 876 092 plošně působící adhesivní přípravek, který obsahuje adhesivní vrstvu, jež obsahuje určité vodorozpustné a ve vodě nerozpustné polymery a ve vodě nerozpustný nosič, který ulpívá na ústní sliznici a při tom dávkuje v ústní dutině účinnou látku.
Všechna tato shora uvedená zařízení nejsou zcela ve vodě rozpustná a setrvávají v ústní dutině i po dosažení terapeutického cíle a způsobují pacientovi v ústech jisté potíže, způsobené hlavně nosnou vrstvou, která v ústech zanechává nerozpustný zbytek.
Byla podniknuta řada pokusů zmenšit v ústní dutině tento nedobrý pocit, který byl způsoben tuhostí a chybějící flexibilitou nosné vrstvy tak, že se zaváděly měkké nosiče filmu. Patenty EP 0 200 508 a EP 0 381 194 navrhují používat jako měkké nosiče polyethylenové filmy, polyvinylacetát, kopolymery ethylen-vinylacetát, kovové fólie, látkové nebo papírové lamináty s plastikovým filmem a podobné materiály, při čemž přednost se dává materiálům ze syntetických pryskyřic jako jsou polyethylen, homopolymery vinylacetátu a kopolymery ethylen-vinylacetát. Stejně tak se v CA 1263 312 pro měkké nosiče publikuje používání polyolefínů jako polyethylenu a polypropylenu, polyesterů. PVC a také roun. Ty však přesto zanechávají u pacienta podstatné množství zbytků ve vodě nerozpustných filmů nosičů a jsou proto stále ještě příčinou nepříjemného pocitu. K překonání tohoto problému bylo nasnadě řešit vývoj filmů ulpívajících na sliznici, které se rozpadnou úplně anebo se rozpustí ve slinách. Fuchs a Hilmann (DE 24 49 865.5) vyrobili ve vodě rozpustné filmy pro ústní podávání hormonů. Pro vytvoření filmu navrhli používat deriváty celulózy jako je hydroxyethylcelulóza, hydroxypropylcelulóza nebo methylhydroxypropylcelulóza. V obou patentech DE 36 30 603 a EP 0 219 762 je na vytvoření filmu popisováno použití bobtnatelných polymerů jako je želatina nebo kukuřičný škrob, které se po aplikaci v ústní dutině pomalu rozpadají a přitom uvolňují aktivně působící látku, která je ve filmu obsažena. Podle popisu v EP 0 452 446 mohou být rovněž použity stejné polymery pro vytvoření filmů, které mají sloužit pro zubní péči. Avšak i tyto přípravky rovněž vyvolávají v ústech nedobrý pocit působený jejich počáteční tuhostí a prodlužovaným změkčováním. Z toho vyplývá poptávka po takové komposici pro použití v ústní dutině, která splní požadavek dobrého pocitu v ústech.
Podstata vynálezu
Předložený vynález popisuje způsob a přípravky, pomocí nichž se lze vyhnout nepříjemnému pocitu, a to poskytnutím jednoho/jedné okamžitou smáčitelnost vykazujícího/vykazující filmu/
-1 CZ 297354 B6 vrstvy pro aplikaci na ústní sliznici a u volného filmu dosažením takové pevnosti v tahu, že bez problémů umožňuje nanášení, další zpracování a balení produktu přitažlivého pro spotřebitele.
Předložený vynález se týká přípravku pro aplikaci v ústní dutině s rychle se rozpouštěj ícím/rozpouštějící filmem/vrstvou, který/á ulpívá v ústní dutině a přitom uvolňuje farmaceuticky nebo kosmeticky účinnou látku a film/vrstva přitom obsahuje jeden nebo více polyalkoholů a jednu nebo více farmaceuticky nebo kosmeticky účinných látek. Volitelně může formulace obsahovat kombinaci určitých změkčovadel nebo povrchově aktivních látek, barviv, sladidel, chuťových přísad, chuť zlepšujících látek nebo jiných korigencií, které u formulací pro aplikaci v ústní dutině mají obvykle použití pro modifikaci chuti. Resultující film se vyznačuje okamžitou smáčitelností, která způsobí, že film bezprostředně po aplikaci na tkáni sliznice změkne, čímž se zabrání delší dobu přetrvávajícímu nepříjemnému pocitu u pacienta, a právě tak se vyznačuje vhodnou pevností v tahu při normálních operacích jako je nanášení, řezání, rozstřihávání a balení.
Předložený vynález se tedy týká přípravku pro aplikaci v ústní dutině s filmem nebo fólií, ulpívající na sliznici s okamžitou smáčitelností, kde film nebo fólie zahrnuje homogenní směs sestávající z
- alespoň jednoho vodorozpustného polymeru,
- směsi neionogenních povrchově aktivních látek,
- alespoň jednoho polylakoholu,
- alespoň jednoho kosmeticky nebo farmaceuticky účinného prostředku a - popřípadě alespoň jedné aromatické přísady, přičemž podle vynálezu směs neionogenních povrchově aktivních látek sestává ze dvou složek, kde první složkou je polyethoxysorbitanový ester mastné kyseliny nebo blokový kopolymer a-hydro-ro-hydroxypoly(ethoxy)-poly-(propoxy)-poly(ethoxy) a druhou složkou je polyethoxyalkylether nebo polyethoxyderivát ricinového oleje a poměr mezi první a druhou složkou binární povrchově aktivní směsi je udržován mezi 1:10 a 1:1.
Mukoadhesivní film podle předkládaného vynálezu obsahuje jako podstatnou část vodorozpustný polymer nebo kombinaci vodorozpustných polymerů, jedno nebo více změkčovadel nebo povrchově aktivních látek, jeden nebo více polyalkoholů a farmaceuticky nebo kosmeticky účinnou látku. Polymery pro mukoadhesivní film zahrnují hydrofilní a/nebo ve vodě dispergovatelné polymery. Preferovanými polymery jsou ve vodě rozpustné deriváty celulózy. Přednost mají zejména hydroxypropylmethylcelulóza, hydroxyethylcelulóza a hydroxypropylcelulóza samotné nebo ve směsi. Aniž by to omezovalo vynález, lze jako příklady pro další případné polymery následovně uvést: polyvinylpyrrolidon, karboxymethylcelulózu, polyvinylalkohol, alginát sodný, polyethylenglykol, přírodní kaučukovité hmoty jako xanthanovou pryskyřici, tragant, guarovou pryskyřici, akaciovou pryskyřici, arabskou gumu, ve vodě dispergovatelné polyakryláty jako kyselinu polyakrylovou, kopolymery methylmethakrylátu, karboxyvinylové kopolymery. Koncentrace vodorozpustného polymeru v hotovém filmu může být mezi 20 a 75 % hmotnostními. Preferovaná koncentrace je mezi 50 a 75 % hmotnostními.
Povrchově aktivními látkami používanými pro mukoadhesivní film může být jedna nebo více neionogenních povrchově aktivních látek. Při použití kombinace povrchově aktivních látek může být první komponentou polyethoxysorbitanový ester mastné kyseliny nebo blokový kopolymer a-hydro-m-hydroxypoly(ethoxy)-poly(propoxy)-poly(ethoxy), zatímco druhou komponentou může být polyethoxyalkylether nebo polyethoxyderivát ricinového oleje.
HLB hodnota polyethoxysorbitanového esteru mastné kyseliny má být nejlépe mezi 10 a 20, přičemž se zvláště dává přednost rozsahu mezi 13 a 17. Blokový kopolymer a-hydro-ro-hydroxypoly(ethoxy)-poly-(propoxy)-poly(ethoxy) má obsahovat nejméně 35 jednotek propoxy, přednost
-2CZ 297354 B6 se dává nejméně 50 jednotkám propoxy. Polyethoxyalkylether by měl mít HLB hodnotu mezi 10 a 20, nejlépe ne méně než 15. Polyethoxyderivát ricinového oleje má mít HLB hodnotu mezi 14 a 16. Aby se dosáhlo požadované okamžité smáčitelnosti, má být poměr mezi první a druhou komponentou binární povrchově aktivní směsi udržován mezi 1:10a 1:1 a přednost se dává mezi 1:5 a 1:3. Celková koncentrace povrchově aktivních látek v hotovém filmu záleží na vlastnostech ostatních ingrediencí, má však obyčejně být mezi 0,1 a 5 % hmotnostními. Polyalkohol je zapotřebí, aby se dosáhl požadovaný stupeň měkkosti. Příklady polyalkoholů zahrnují glycerol, polyethylenglykol, propylenglykol, monoestery glycerolu s mastnými kyselinami nebo jiné, farmaceuticky používané polyalkoholy. Koncentrace polyalkoholů v suché hmotě filmu obvykle obnáší 0,1 až 5 % hmotnostních.
Film se zvlášť dobře hodí k podávání široké škály farmaceuticky aktivních účinných látek prostřednictvím membrán sliznic pacienta, zejména prostřednictvím ústních sliznic. Zvlášť dobře se hodí terapeuticky účinné látky, u kterých jsou problémy s absorpcí vlivem omezené rozpustnosti, s odbouráváním v gastrointestinálním traktu nebo vlivem extensivního metabolismu. Jako příklady použitelných terapeuticky aktivních látek lze jmenovat: hypnotika, sedativa, antiepileptika, stimulační aminy, psychoneurotropika, svalové neuroblokátory, antispasmodika, antihistaminika, antialergika, kardiotonika, antiarhytmika, diuretika, hypotenziva, vasopressory, antitussiva, expektorancia, thyroidní hormony, sexuální hormony, antidiabetika, přípravky účinné proti nádorům, antibiotika a také chemoterapeutika a narkotika. Do filmu uložené množství účinné látky závisí na jejím druhu a obvykle obnáší mezi 0,01 a 20 % hmotnostními, avšak pokud je to pro docílení požadovaného účinku nutné, může být i vyšší.
Kosmeticky účinné látky zahrnují osvěžovače dechu jako menthol, jiné chuťové, aromatické nebo vonné látky, které se obvykle používají v ústní hygieně, a/nebo účinné látky pro zubní péči a/nebo ústní hygienu, na příklad kvartémí amoniové zásady. Působení chuťových a aromatických látek se zesiluje látkami, které zdůrazňují chuť jako je kyselina vinná, kyselina citrónová, vanilin nebojím podobné. Barviva, která mohou být případně do filmu přimíšena, musí být bezpečná z hlediska toxicity a musí být příslušnými úřady schválena pro použití v kosmetice.
Mukoadhesivní film podle vynálezu může být zhotoven následujícím způsobem:
Polyalkohol, povrchově aktivní látky, změkčovadla a jiné případné složky mimo vodorozpustného(ných) nebo ve vodě dispergovatelného (ných) polymeru(ů) se rozpustí v dostatečném množství kompatibilního rozpouštědla. Příklady kompatibilního rozpouštědla zahrnují vodu, alkoholy nebo jejich směsi. Po vzniku čirého roztoku se pomalu, za stálého míchání a pokud je to nutné za zahřívání, přidává ve vodě dispergovatelný polymer nebo směs ve vodě dispergovatelných polymerů až se vytvoří čirý a homogenní roztok. Ten se nanese na nosič a vysuší na film. Materiál nosiče musí mít takové povrchové napětí, aby umožnilo rovnoměrně rozvrstvit roztok polymeru po celé předpokládané šířce, aniž by se roztok vsákl a tím vzniklo destruktivní spojení mezi nosičem a nanášenou vrstvou.
Mezi příklady pro vhodné materiály nosičů patří nesilikonizované filmy polyethylen-tereftalát, nesilikonizovaný sulfátový „kraft” papír, sulfátový „kraft” papír impregnovaný polyethylenem nebo nesilikonisovaný polyethylenový film. Nanesení roztoku na nosný materiál je možné provádět každým běžným zařízením. Speciálně oblíbená nanášecí technika se týká natíracího stroje s válcovou stěrkou. Tloušťka vzniklé filmové vrstvy závisí na koncentraci pevných látek v nanášeném roztoku a také na šířce štěrbiny natíracího stroje a může se pohybovat mezi 5 a 200 pm. Sušení se provádí za použití sušárny, sušícího tunelu, vakuové sušičky nebo jiných vhodných sušicích zařízení, které negativně neovlivňují působení účinné(ných) látky(látek) nebo chuťových látek. Aby se spolehlivě vyvaroval nepříjemný pocit v ústech, nemá tloušťka filmové vrstvy překročit 70 pm. Pro lepší usnadnění používání může být film nařezán na kousky vhodné velikostí a formy a zabalen. Vynález je názorně popisován v následujících příkladech.
-3 CZ 297354 B6
Příklad provedení vynálezu
Příklad 1 g sorbitolu, 6g glycerolu, 0,5 g polysorbátu (Tween 80 = polyoxymethylen[20] sorbitan monooleát), 2 g Brij 35 (= polyoxyethylen[23] lauryl ether), 25 g aroma máty citrónové, 3 g Aspartamu, 15 g 1-mentholu a 3 g kyseliny citrónové bylo při 60 °C ve směsi 250 g vody a 250 g ethanolu mícháno tak dlouho, až vznikl čirý roztok. K roztoku bylo pomalu za míchání přidáváno 30 g hydroxypropylmethylcelulózy, až se vytvořil čirý a homogenní roztok. Vzniklý roztok se potom nechal ochladit na teplotu místnosti a za použití obvyklého nanášecího/sušícího zařízení byl nanesen na vhodný nosný materiál, například na nesilikonizovaný sulfátový „krafit” papír potažený polyethylenem. Štěrbina pro nanášení a rychlost po dráze musí být nařízeny tak, aby se dosáhlo u suchého filmu tloušťky mezi 20 a 50 pm. Teplota při sušení je závislá na délce sušicí pece rychlosti pohybu materiálu a má být nastavena tak, aby se z filmu rozpouštědlo odstranilo úplně nebo alespoň z největší části. Vzniklý film se sejme z nosiče a pro použití se rozdělí na kousky vhodné velikosti a tvaru.
Příklad 2 g sorbitolu, 1,5 g Kollidonu 30 (dodavatel BASF), 5 g glycerolu, 5 g propylenglykolu, 4 g polysorbátu (Tween 80 - polyoxymethylen[20] sorbitan monooleát), 8 g Brij 35 (= polyoxyethylen[23] lauryl ether), 12 g aroma máty pepmé, 0,8 g Aspartamu, bylo při 60 °C za míchání rozpuštěno ve směsi 400 g vody a 400 g ethanolu. K čirému roztoku bylo pomalu za míchání přidáváno 28 g hydroxypropylmethylcelulózy. Po úplném rozpuštění polymeru se roztok ochladil na teplotu místnosti a byl nanesen na nosič za stejných podmínek při nanášení a sušení jako v příkladu 1. Suchý film byl opět rozdělen na kousky vhodné velikosti a tvaru.
Příklad 3 g sorbitolu, 22,5 g glycerolu, 2,5 g propylenglykolu, 2,5 g Brij 35 (= polyoxyethylen[23] lauryl ether), 2,5 g Poloxameru 407, 3,5 g Cremophoru RH 40, 9,5 g aroma máty klasnaté, 0,5 g Aspartamu, bylo při 60 °C za stálého míchání rozpuštěno ve směsi 250 g vody a 250 g ethanolu. K čirému roztoku bylo pomalu za míchání přidáváno 75 g hydroxypropylcelulózy. Čirý roztok byl jako v příkladu 1 nanesen a vysušen; vysušený film byl opět rozdělen na kousky vhodné velikosti a tvaru.
Příklad 4
3,6 g Tween 80 (= polyoxymethylen[20] sorbitan monooleát), 3,6 g glycerolu, 39 g mentholu a 171 g Kollidonu 30 bylo za míchání při teplotě místnosti rozpuštěno v roztoku 600 ml vody a 2800 ml ethanolu. Potom bylo při 50 až 55 °C pomalu po dávkách přidáno 247,5 g hydroxypropylmethylcelulózy; mícháno bylo až do úplného rozpuštění. Po ochlazení směsi bylo za míchání přidáno postupně 90 g aroma máty citrónové, následovaných roztokem/suspensí 27,13 g Aspartamu, 18 g kyseliny citrónové a 0,17 g FD&C žlutě # 5 ve 120 ml vody. Čirý roztok byl za podmínek popsaných v příkladu 1 nanesen na nosič a vysušen; suchý film byl rozdělen na kousky vhodné velikosti a tvaru pro zamýšlené použití.
Příklad 5
165,4 g Kollidonu 30 bylo za míchání při teplotě místnosti rozpuštěno v roztoku 720 ml vody a 2660 ml ethanolu. Potom bylo při 55 až 60 °C přidáno 220,5 g hydroxypropylmethylcelulózy a tak dlouho intensivně mícháno, až byl roztok čirý a homogenní. Po ochlazení bylo do směsi po
-4CZ 297354 B6 řadě za míchání přidáno 78,75 g ochucovací látky následované směsí 26,88 g salicylátu nikotinu a 31,5 g kapalného karamelu ve 120 ml vody. Čirá, žlutohnědá kapalina byla za podmínek popsaných v příkladu 1 natřena a usušena a suchý film byl rozdělen na kousky vhodného tvaru a velikosti pro podávání nikotinové dávky 1 až 2 mg v jednom kousku.
Claims (10)
- PATENTOVÉ NÁROKY1. Přípravek pro aplikaci v ústní dutině s filmem nebo fólií, ulpívající na sliznici s okamžitou smáčitelností, kde film nebo fólie zahrnuje homogenní směs sestávající z- alespoň jednoho vodorozpustného polymeru,- směsi neionogenních povrchově aktivních látek,- alespoň jednoho polylakoholu,- alespoň jednoho kosmeticky nebo farmaceuticky účinného prostředku a- popřípadě alespoň jedné aromatické přísady, vyznačující se tím, že směs neionogenních povrchově aktivních látek sestává ze dvou složek, přičemž první složkou je polyethoxysorbitanový ester mastné kyseliny nebo blokový kopolymer a-hydro-ro-hydroxypoly(ethoxy)-poly-(propoxy)-poly(ethoxy) a druhou složkou je polyethoxyalkylether nebo polyethoxyderivát ricinového oleje, přičemž poměr mezi první a druhou složkou binární povrchově aktivní směsi je udržován mezi 1:10 a 1:1.
- 2. Přípravek podle nároku 1, vyznačující se tím, že poměr mezi první a druhou složkou binární směsi je mezi 1:5 a 1:3.
- 3. Přípravek podle nároku 1 nebo 2, vyznačující se tím, že HLB hodnota polyethoxysorbitanového esteru mastné kyseliny je mezi 10 a 20.
- 4. Přípravek podle kteréhokoli z předcházejících nároků, vyznačující se tím, žeHLB hodnota polyethoxyalkylether je mezi 10 a 20.
- 5. Přípravek podle kteréhokoli z předcházejících nároků, vyznačující se tím, že polyethoxyderivát ricinového oleje má HLB hodnotu 14 až 16.
- 6. Přípravek podle kteréhokoli z předcházejících nároků, vyznačující se tím, že blokový kopolymer a-hydro-ro-hydroxypoly(ethoxy)-poly-(propoxy)-poly(ethoxy) obsahuje alespoň 35 propoxy jednotek.
- 7. Přípravek podle kteréhokoli z předcházejících nároků, vyznačující se tím, že vodorozpustný polymer je vybrán ze skupiny sestávající z hydroxypropylmethylcelulózy, hydroxyethylcelulózy, hydroxypropylcelulózy, polyvinylpyrrolidonu, karboxymethylcelulózy, polyvinylakoholu, alginátu sodného, polyethylenglykolu, xanthanové pryskyřice, tragantu, guarové gumy, akaciové gumy, arabské gumy, polyakrylové kyseliny, methylmethakrylátového kopolymeru, karboxyvinylových kopolymerů nebo jejich směsí.
- 8. Přípravek podle kteréhokoli z předcházejících nároků, vyznačující se tím, že polyalkohol je vybrán ze skupiny sestávající z glycerolu, polyethylenglykolu, propylenglykolu a monoesterů glycerolu s mastnými kyselinami.-5CZ 297354 B6
- 9. Přípravek podle kteréhokoli z předcházejících nároků, vyznačující se tím, že farmaceuticky účinný prostředek je vybrán ze skupiny sestávající z hypnotik, sedativ, antiepileptik, psychostimulačních aminů, psychoneurotropních prostředků, neuromuskulámích blokátorů, antispasmodik, antihistaminik, antialergik, kardiotonik, antiarytmik, diuretik, hypotenziv,5 vasopresorů, antitusiv, expektorancií, protinádorově účinných látek, thyroidních hormonů, pohlavních hormonů, antidiabetik, antibiotik, chemoterapeutik nebo narkotik.
- 10. Přípravek podle nároku 1, vyznačující se tím, že kosmeticky účinná látka je vybrána ze skupiny sestávající z osvěžovačů dechu jako je menthol, chuťových, aromatických ío nebo vonných látek používaných v ústní hygieně a/nebo účinných látek pro zubní péči a ústní hygienu jako jsou kvartemí amoniové zásady.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19646392A DE19646392A1 (de) | 1996-11-11 | 1996-11-11 | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| PCT/EP1997/005820 WO1998020862A1 (de) | 1996-11-11 | 1997-10-22 | Sofortige benetzbarkeit aufweisende(r) wasserlöslicher film oder wasserlösliche schicht zur oralen applikation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ164799A3 CZ164799A3 (cs) | 1999-08-11 |
| CZ297354B6 true CZ297354B6 (cs) | 2006-11-15 |
Family
ID=7811214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ0164799A CZ297354B6 (cs) | 1996-11-11 | 1997-10-22 | Prípravek pro aplikaci v ústní dutine s filmem nebo fólií s okamzitou smácitelností |
Country Status (25)
| Country | Link |
|---|---|
| US (8) | US5948430A (cs) |
| EP (2) | EP0936905B1 (cs) |
| JP (3) | JP4063331B2 (cs) |
| KR (2) | KR100604995B1 (cs) |
| AT (2) | ATE422157T1 (cs) |
| AU (1) | AU739698B2 (cs) |
| CA (1) | CA2265651C (cs) |
| CZ (1) | CZ297354B6 (cs) |
| DE (4) | DE19646392A1 (cs) |
| DK (2) | DK1362584T3 (cs) |
| ES (2) | ES2322699T3 (cs) |
| HU (2) | HU230022B1 (cs) |
| ID (1) | ID22526A (cs) |
| IL (2) | IL129819A0 (cs) |
| MY (1) | MY125548A (cs) |
| NO (2) | NO325073B1 (cs) |
| NZ (1) | NZ335063A (cs) |
| PL (1) | PL190376B1 (cs) |
| PT (2) | PT936905E (cs) |
| SI (1) | SI0936905T1 (cs) |
| SK (2) | SK285100B6 (cs) |
| TR (1) | TR199901633T2 (cs) |
| TW (2) | TWI250029B (cs) |
| WO (1) | WO1998020862A1 (cs) |
| ZA (1) | ZA9710093B (cs) |
Families Citing this family (413)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19636001A1 (de) * | 1996-09-05 | 1998-03-12 | Hoechst Ag | Sulfoxidgruppenhaltige Polymermischungen |
| US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
| DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| US20050048102A1 (en) * | 1997-10-16 | 2005-03-03 | Virotex Corporation | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| DE19832169A1 (de) * | 1998-07-17 | 2000-01-27 | Jenapharm Gmbh | Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle |
| US20020098264A1 (en) * | 1998-11-27 | 2002-07-25 | Cherukuri Subraman R. | Medicated chewing gum delivery system for nicotine |
| US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
| US20030206942A1 (en) * | 1998-09-25 | 2003-11-06 | Neema Kulkarni | Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent |
| US6596298B2 (en) * | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
| US20030211136A1 (en) * | 1998-09-25 | 2003-11-13 | Neema Kulkarni | Fast dissolving orally consumable films containing a sweetener |
| MXPA01005346A (es) * | 1998-11-27 | 2003-03-27 | Kanji Takada | Una formulacion oral para suministro de farmaco gastrointestinal. |
| DE19856101A1 (de) * | 1998-12-04 | 2000-06-08 | Labtec Gmbh | Mundhöhlen-Matrixpflaster |
| EP1139793B1 (en) | 1998-12-23 | 2009-10-14 | Mount Sinai School of Medicine of New York University | Inhibitors of the bitter taste response |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
| EP1152749B1 (en) † | 1999-02-08 | 2006-04-12 | ALZA Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| DE19911262C2 (de) * | 1999-03-13 | 2003-04-10 | Scs Skin Care Systems Gmbh | Vorrichtung zur Abgabe kosmetischer Wirkstoffe |
| US6231957B1 (en) * | 1999-05-06 | 2001-05-15 | Horst G. Zerbe | Rapidly disintegrating flavor wafer for flavor enrichment |
| AU5907300A (en) | 1999-07-02 | 2001-01-22 | Procter & Gamble Company, The | Compositions comprising organosiloxane resins for delivering xylitol to the oralcavity |
| US7314716B2 (en) | 1999-11-19 | 2008-01-01 | Mount Sinai School Of Medicine | Gustducin γ subunit materials and methods |
| DE10001096A1 (de) * | 2000-01-13 | 2001-07-26 | Lohmann Therapie Syst Lts | TTS mit Reservoirschicht zur Aufnahme und Abgabe von Duftstoffen |
| US6387356B1 (en) | 2000-01-27 | 2002-05-14 | Colgate-Palmolive Company | Cosmetic composition |
| US7067116B1 (en) * | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
| US20020013331A1 (en) * | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
| DE10032456A1 (de) * | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
| USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| DE10034491A1 (de) * | 2000-07-15 | 2002-01-24 | Scs Skin Care Systems Gmbh | Folien-Dermatika |
| DE10050267A1 (de) * | 2000-10-09 | 2001-12-06 | Karen Croissant | Mittel zum Reinigen der Zähne und/oder des Mundes |
| US20020131990A1 (en) * | 2000-11-30 | 2002-09-19 | Barkalow David G. | Pullulan free edible film compositions and methods of making the same |
| US20060062864A1 (en) * | 2000-12-28 | 2006-03-23 | Mccleary Edward L | Weight loss composition and method |
| US20040043013A1 (en) | 2000-12-28 | 2004-03-04 | Mccleary Edward Larry | Metabolic uncoupling therapy |
| EP1370206A4 (en) * | 2001-01-09 | 2006-04-05 | Lavipharm Lab Inc | DEVICES FOR THE TOPICAL AND SYSTEMIC DISTRIBUTION OF ACTIVE SUBSTANCES AND METHOD FOR THE PRODUCTION THEREOF |
| DE10107659B4 (de) * | 2001-02-19 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin |
| US20060110478A1 (en) * | 2004-11-22 | 2006-05-25 | Mccleary Edward L | Delivery system and method for supporting and promoting healthy sexual function and prevention and treatment of sexual dysfunction |
| EP1389910A4 (en) * | 2001-04-20 | 2005-11-02 | Lavipharm Lab Inc | INTRABUCAL DISTRIBUTION OF NICOTINE INTENDED TO STOP SMOKING |
| US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
| EP1390085B1 (en) | 2001-05-01 | 2009-08-05 | A.V. Topchiev Institute of Petrochemical Synthesis | Hydrogel compositions |
| CA2447302C (en) | 2001-05-01 | 2008-07-29 | A.V. Topchiev Institute Of Petrochemical Synthesis | Two-phase, water-absorbent bioadhesive composition |
| US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
| US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
| US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
| US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
| US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
| US6660292B2 (en) * | 2001-06-19 | 2003-12-09 | Hf Flavoring Technology Llp | Rapidly disintegrating flavored film for precooked foods |
| US6656493B2 (en) * | 2001-07-30 | 2003-12-02 | Wm. Wrigley Jr. Company | Edible film formulations containing maltodextrin |
| HUP0401022A3 (en) * | 2001-08-14 | 2006-11-28 | Biotie Therapies Corp | Method for the preparation of pharmaceutical compositions containing opioid antagonist for treating alcoholism or alcohol abuse |
| US6419903B1 (en) * | 2001-08-20 | 2002-07-16 | Colgate Palmolive Company | Breath freshening film |
| US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
| US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US7425292B2 (en) * | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| US8663687B2 (en) | 2001-10-12 | 2014-03-04 | Monosol Rx, Llc | Film compositions for delivery of actives |
| AU2002348432B2 (en) * | 2001-10-12 | 2007-08-09 | Aquestive Therapeutics, Inc. | Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform |
| US7666337B2 (en) * | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US20060039958A1 (en) * | 2003-05-28 | 2006-02-23 | Monosolrx, Llc. | Multi-layer films having uniform content |
| US7910641B2 (en) * | 2001-10-12 | 2011-03-22 | Monosol Rx, Llc | PH modulated films for delivery of actives |
| US20100021526A1 (en) * | 2001-10-12 | 2010-01-28 | Monosol Rx, Llc | Ph modulated films for delivery of actives |
| US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
| US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US20070154527A1 (en) * | 2001-10-12 | 2007-07-05 | Monosoirx, Llc | Topical film compositions for delivery of actives |
| US7357891B2 (en) * | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
| US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
| US20030099691A1 (en) * | 2001-11-16 | 2003-05-29 | Susan Lydzinski | Films containing starch |
| CN1585650A (zh) * | 2001-11-16 | 2005-02-23 | 吉万奥丹股份有限公司 | 可食性薄膜 |
| KR100843001B1 (ko) * | 2002-01-16 | 2008-07-01 | 동화약품공업주식회사 | 구강점막 부착형 필름제제 |
| WO2003059542A1 (en) | 2002-01-17 | 2003-07-24 | Lts Lohmann Therapie-Systeme Ag | Method for neutralizing or recycling carrier materials for film-like coatings |
| US20050100640A1 (en) * | 2002-02-11 | 2005-05-12 | Pearce Tony M. | Microcapsule edibles |
| US20050003048A1 (en) * | 2002-02-11 | 2005-01-06 | Edizone, Lc | Electrolyte-containing orally soluble films |
| US20040247649A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Medicine-containing orally soluble films |
| US20040247746A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Delivery units of thick orally soluble polymer |
| US20040247744A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Vitamin-containing orally soluble films |
| US20030224090A1 (en) * | 2002-02-11 | 2003-12-04 | Edizone, Lc | Snacks of orally soluble edible films |
| AU2003211051A1 (en) * | 2002-02-13 | 2003-09-04 | Michael K. Weibel | Drug dose-form and method of manufacture |
| KR20030075213A (ko) * | 2002-03-16 | 2003-09-26 | (주)케비젠 | 항암물질을 함유하는 수용성 필름제 및 이의 제조방법 |
| US20030194420A1 (en) * | 2002-04-11 | 2003-10-16 | Richard Holl | Process for loading a drug delivery device |
| US8017150B2 (en) | 2002-04-11 | 2011-09-13 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| WO2003099263A1 (de) * | 2002-05-24 | 2003-12-04 | Agfa-Gevaert | Wirkstoff enthaltende, zumindest teilweise abbaubare folien und verfahren zuderen herstellung |
| DE10224607B4 (de) * | 2002-06-04 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung |
| US6937455B2 (en) | 2002-07-03 | 2005-08-30 | Kronos Advanced Technologies, Inc. | Spark management method and device |
| RU2338549C2 (ru) * | 2002-06-25 | 2008-11-20 | Вм. Ригли Дж. Компани | Продукт с экстрактом коры магнолии, освежающий дыхание и дезинфицирующий полость рта |
| US7347985B2 (en) * | 2002-06-25 | 2008-03-25 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product with magnolia bark extract |
| US7632525B2 (en) * | 2002-06-25 | 2009-12-15 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents |
| US7595065B2 (en) * | 2002-06-25 | 2009-09-29 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils |
| US7053565B2 (en) | 2002-07-03 | 2006-05-30 | Kronos Advanced Technologies, Inc. | Electrostatic fluid accelerator for and a method of controlling fluid flow |
| US7150780B2 (en) * | 2004-01-08 | 2006-12-19 | Kronos Advanced Technology, Inc. | Electrostatic air cleaning device |
| US20030017208A1 (en) * | 2002-07-19 | 2003-01-23 | Francis Ignatious | Electrospun pharmaceutical compositions |
| EP1542903B1 (en) * | 2002-07-22 | 2015-05-20 | MonoSolRX, LLC | Packaging and dispensing of rapid dissolve dosage form |
| US7429619B2 (en) | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
| US6824829B2 (en) * | 2002-08-23 | 2004-11-30 | Acupac Packaging, Inc. | Process for manufacturing thin film strips |
| US7241411B2 (en) * | 2002-08-23 | 2007-07-10 | Acupac Packaging, Inc. | Thin film strips |
| WO2004019802A2 (en) * | 2002-08-27 | 2004-03-11 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product using carvacrol |
| US20040043134A1 (en) * | 2002-08-27 | 2004-03-04 | Corriveau Christine Leclair | Rolled edible thin film products and methods of making same |
| EP1534252B1 (en) * | 2002-08-27 | 2010-06-30 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product using cardamom oil |
| US20040120991A1 (en) * | 2002-09-07 | 2004-06-24 | Mars Incorporated | Edible films having distinct regions |
| US8524200B2 (en) | 2002-09-11 | 2013-09-03 | The Procter & Gamble Company | Tooth whitening products |
| US20050019277A1 (en) * | 2002-09-11 | 2005-01-27 | The Procter & Gamble Company | Tooth whitening products |
| US6916463B2 (en) * | 2002-09-24 | 2005-07-12 | The Procter & Gamble Company | Oral products having an aesthetic layer |
| US6800295B2 (en) * | 2002-10-09 | 2004-10-05 | The Dial Corporation | Water soluble sheet composition |
| FI20022007A0 (fi) * | 2002-11-08 | 2002-11-08 | Juvantia Pharma Ltd Oy | Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi |
| GB0226076D0 (en) * | 2002-11-08 | 2002-12-18 | Rp Scherer Technologies Inc | Improved formulations containing substituted imidazole derivatives |
| DE10252726B4 (de) * | 2002-11-13 | 2008-05-08 | Lts Lohmann Therapie-Systeme Ag | Mehrschichtiges transmucosales therapeutisches System |
| US9561182B2 (en) * | 2003-08-22 | 2017-02-07 | Cure Pharmaceutical Corporation | Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals |
| WO2004043165A1 (en) * | 2002-11-14 | 2004-05-27 | Givaudan Sa | Edible film containing food acid |
| MXPA05005243A (es) * | 2002-11-14 | 2006-03-10 | Innozen Inc | Pelicula comestible para el alivio de la tos o sontomas relacionados con la faringitis. |
| US8999372B2 (en) * | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
| US20040191302A1 (en) | 2003-03-28 | 2004-09-30 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
| US20040131662A1 (en) * | 2003-11-12 | 2004-07-08 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
| US20040111275A1 (en) * | 2002-11-15 | 2004-06-10 | Kroll David B. | Methods for marketing and generating revenue from edible thin films |
| US20040096569A1 (en) * | 2002-11-15 | 2004-05-20 | Barkalow David G. | Edible film products and methods of making same |
| US8071123B2 (en) | 2002-12-02 | 2011-12-06 | Kyukyu Pharmaceutical Co., Ltd. | Process for producing edible orally administered agent of laminate film form and compression bonding apparatus |
| AU2003289183B2 (en) * | 2002-12-04 | 2009-09-10 | Hokkai Sankyo Co., Ltd. | Method of preventing wheat from mycotoxin contamination |
| DE10256775A1 (de) * | 2002-12-05 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Filmförmige Zubereitungen zur transmucosalen Verabreichung von Nicotin, sowie Verfahren zu deren Herstellung |
| WO2004052335A1 (en) * | 2002-12-06 | 2004-06-24 | Monosolrx Llc | Thin film delivery systems for volatile decongestants |
| US20040115137A1 (en) * | 2002-12-17 | 2004-06-17 | Verrall Andrew P. | Water-soluble film for oral administration |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
| ATE553746T1 (de) | 2003-01-30 | 2012-05-15 | Monosolrx Llc | Verfahren zur herstellung eines dünnen films, thermolabile wirkstoffe enthaltend |
| US20040156794A1 (en) * | 2003-02-11 | 2004-08-12 | Barkalow David G. | Bioerodible and bioadhesive confectionery products and methods of making same |
| US7041311B2 (en) * | 2003-02-28 | 2006-05-09 | International Flavors & Fragrances Inc. | Preparation for saliva flow |
| US20040228892A1 (en) * | 2003-02-28 | 2004-11-18 | Berry Craig J. | Delivery system for cosmetic and skincare products |
| MXPA05010201A (es) * | 2003-03-26 | 2005-11-08 | Procter & Gamble | Composiciones de pelicula comestible que se disuelve rapidamente con polimeros formadores de pelicula de celulosa. |
| EP1605908A2 (en) * | 2003-03-26 | 2005-12-21 | The Procter & Gamble Company | Rapidly dissolving edible film compositions with improved film strength and stability |
| US20040202698A1 (en) * | 2003-04-02 | 2004-10-14 | The Procter & Gamble Company | Drug delivery systems comprising an encapsulated active ingredient |
| US20050013847A1 (en) * | 2003-04-14 | 2005-01-20 | Fmc Corporation | Delivery systems of homogeneous, thermoreversible alginate films |
| MXPA05011026A (es) * | 2003-04-14 | 2005-12-12 | Fmc Corp | Pelicula de gel termo-reversible homogenea que contiene carragenano kappa-2 y capsulas blandas hechas a partir de la misma. |
| US20050019294A1 (en) * | 2003-04-14 | 2005-01-27 | Fmc Corporation | Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
| US7306812B2 (en) | 2003-05-09 | 2007-12-11 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
| US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
| CA2544776C (en) | 2003-05-28 | 2014-04-15 | Monosolrx Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| GB0312425D0 (en) * | 2003-05-30 | 2003-07-09 | Boots Co Plc | Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| US20040241294A1 (en) * | 2003-05-31 | 2004-12-02 | Barabolak Roman M. | Edible films including aspartame and methods of making same |
| US8703209B2 (en) * | 2003-06-17 | 2014-04-22 | Edward Larry McCleary | Composition and method for modulating hydrogen ion physiology |
| DE602004008072T3 (de) * | 2003-06-23 | 2011-05-12 | Colgate-Palmolive Co. | Stabile zahnreinigungszusammensetzungen |
| US20040258630A1 (en) * | 2003-06-23 | 2004-12-23 | Boyd Thomas J. | Antiplaque breath freshening consumable film |
| US8287843B2 (en) * | 2003-06-23 | 2012-10-16 | Colgate-Palmolive Company | Antiplaque oral care compositions |
| DE10328942A1 (de) * | 2003-06-27 | 2005-01-27 | Lts Lohmann Therapie-Systeme Ag | Transmukosale Darreichungsformen mit verminderter Schleimhautirritation |
| PT2446881E (pt) | 2003-07-24 | 2014-06-11 | Glaxosmithkline Llc | Películas de dissolução oral |
| US7666396B2 (en) * | 2003-09-11 | 2010-02-23 | Kimberly-Clark Worldwide, Inc. | Single-use moisturizing product |
| US20050080039A1 (en) * | 2003-10-14 | 2005-04-14 | Cp Kelco, U.S., Inc. | Pectin films prepared from gamma irradiated pectin |
| CA2543350C (en) | 2003-10-24 | 2011-04-26 | Adhesives Research, Inc. | Disintegratable films for diagnostic devices |
| US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
| WO2005046363A2 (en) | 2003-11-07 | 2005-05-26 | U.S. Smokeless Tobacco Company | Tobacco compositions |
| WO2005048931A2 (en) * | 2003-11-13 | 2005-06-02 | Dbc, Llc | Dissolving thin film xanthone supplement |
| DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
| DE10358747A1 (de) * | 2003-12-12 | 2005-07-07 | Lts Lohmann Therapie-Systeme Ag | Darreichungsform basierend auf vernetzten hydrophilen Polymeren |
| EP2105122B1 (en) * | 2003-12-16 | 2012-09-26 | Colgate-Palmolive Company | Oral and personal care compositions and methods |
| DE102004002951A1 (de) * | 2004-01-21 | 2005-08-11 | Wella Ag | Verfahren zur Herstellung haarfestigender Produkte in Folienform |
| FR2865130B1 (fr) * | 2004-01-21 | 2007-10-05 | Oreal | Film anhydre pour le maquillage ou le soin des levres. |
| US8658201B2 (en) | 2004-01-30 | 2014-02-25 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
| US20050186256A1 (en) * | 2004-02-20 | 2005-08-25 | Dihel Deborah L. | Dissolvable film comprising an active ingredient and method of manufacture |
| US20050196354A1 (en) * | 2004-03-03 | 2005-09-08 | Andre Soshinsky | Film compositions |
| US20070269519A1 (en) * | 2004-03-03 | 2007-11-22 | Constantine Georgiades | Whitening products |
| US20070190125A1 (en) * | 2004-03-03 | 2007-08-16 | Constantine Georgiades | Positioning feature for aiding use of film or strip product |
| US20050196348A1 (en) * | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Stabilized peroxide compositions |
| US20050196355A1 (en) * | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Film products having controlled disintegration properties |
| US20080003248A1 (en) * | 2004-03-03 | 2008-01-03 | Constantine Georgiades | Whitening products |
| KR20060115766A (ko) * | 2004-03-03 | 2006-11-09 | 워너-램버트 캄파니 엘엘씨 | 필름 조성물 |
| US20050208108A1 (en) * | 2004-03-19 | 2005-09-22 | Jannusch Leonard C | Thermoplastic films and methods for making |
| US7785619B2 (en) * | 2004-04-08 | 2010-08-31 | Micro Nutrient, Llc | Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| US7850987B2 (en) * | 2004-04-08 | 2010-12-14 | Micronutrient, Llc | Nutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| WO2005097085A1 (en) * | 2004-04-08 | 2005-10-20 | Micro Nutrient, Llc | Nutrient system for individualized responsive dosing regimens |
| NZ551336A (en) * | 2004-04-22 | 2010-04-30 | Acucort Ab | Pharmaceutical compositions for acute glucocorticoid therapy |
| WO2005107811A2 (en) * | 2004-05-04 | 2005-11-17 | Perry Victor A | Drug delivery device |
| US7399482B1 (en) | 2004-05-07 | 2008-07-15 | Christine Horner Biernacki | Thin film medication device and kit |
| US7972589B2 (en) * | 2004-05-17 | 2011-07-05 | Akzo Nobel N.V. | Hair fixative film |
| EP1758554A1 (en) * | 2004-06-12 | 2007-03-07 | Passion For Life Healthcare Limited | Soluble strip for oral or topical adminstration |
| EP1773366A4 (en) * | 2004-06-22 | 2009-11-11 | E L Management Corp | SOLUBLE FILM COMPOSITION |
| US20060024425A1 (en) * | 2004-07-30 | 2006-02-02 | Wm. Wrigley Jr. Company | Edible film compositions |
| CA2576158C (en) | 2004-08-05 | 2020-10-27 | Corium International, Inc. | Adhesive composition |
| DE102005003387A1 (de) * | 2004-09-01 | 2006-03-02 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Atrium Patch |
| PT1791791T (pt) * | 2004-09-27 | 2019-09-12 | Special Water Patents B V | Métodos e composições para tratamento de água |
| US20060073190A1 (en) * | 2004-09-30 | 2006-04-06 | Carroll Thomas J | Sealed, edible film strip packets and methods of making and using them |
| JP4898113B2 (ja) * | 2004-12-02 | 2012-03-14 | リンテック株式会社 | 経口投与剤 |
| US9198897B2 (en) | 2005-01-19 | 2015-12-01 | Neurohealing Pharmaceuticals, Inc. | Methods and compositions for decreasing saliva production |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| DE102005007859A1 (de) * | 2005-02-21 | 2006-08-24 | Lts Lohmann Therapie-Systeme Ag | Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen |
| US7992575B2 (en) * | 2005-02-28 | 2011-08-09 | U.S. Smokeless Tobacco Company | Use of chlorate, sulfur or ozone to reduce tobacco specific nitrosamines |
| CA2600462C (en) * | 2005-03-10 | 2013-07-30 | Mary Kay Inc. | Compositions comprising entrained water and agents entrained in water-sensitive matrices |
| DE102005015128B4 (de) * | 2005-03-31 | 2008-12-11 | Bayer Schering Pharma Aktiengesellschaft | Wafer enthaltend Steroidhormone |
| US7410532B2 (en) | 2005-04-04 | 2008-08-12 | Krichtafovitch Igor A | Method of controlling a fluid flow |
| US20060228307A1 (en) * | 2005-04-08 | 2006-10-12 | Cao Group, Inc. | Structures and methods for delivering topical compositions |
| WO2006119286A1 (en) * | 2005-05-03 | 2006-11-09 | Innozen, Inc. | Edible film for transmucosal delivery of nutritional supplements |
| US20060260366A1 (en) * | 2005-05-18 | 2006-11-23 | I+Dcreative, Llc | Laundry appliance for washing small quantities of clothing |
| CN101262786B (zh) * | 2005-05-25 | 2015-04-08 | 美国无烟烟草有限责任公司 | 烟草组合物 |
| US20060275364A1 (en) * | 2005-05-26 | 2006-12-07 | Ahmed Salah U | Flexible Solid Dosage Forms and Methods of Making and Using the Same |
| EP1888025B1 (en) * | 2005-06-08 | 2020-08-12 | Basf Corporation | Medicament carrier composition and method of forming a film therefrom |
| DE102005033543A1 (de) * | 2005-07-14 | 2007-01-18 | Grünenthal GmbH | Ein einen Duftstoff aufweisendes transdermales therapeutisches System |
| DE102005033943A1 (de) * | 2005-07-20 | 2007-02-22 | Hexal Ag | Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum |
| WO2007013962A2 (en) * | 2005-07-21 | 2007-02-01 | Neurohealing Pharmaceuticals, Inc. | Rapid onset and short term modafinil compositions and methods of use thereof |
| MX2008001532A (es) * | 2005-08-02 | 2008-04-22 | Drossapharm Ag | Composicion farmaceutica que contiene indometacina y/o acemetacina. |
| EP3871693A1 (en) | 2005-09-27 | 2021-09-01 | Special Water Patents B.V. | Compositions for oral care |
| US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
| EP1951326A2 (en) | 2005-11-04 | 2008-08-06 | Lifescience Plus, Inc. | Bioabsorbable hemostatic gauze |
| US20070104769A1 (en) * | 2005-11-04 | 2007-05-10 | Lifescience Plus, Inc. | Bioabsorbable hemostatic gauze |
| US7470442B2 (en) * | 2005-12-02 | 2008-12-30 | Gic Innovations Company | Confectionary compositions with magnolia bark extract |
| CN101321560B (zh) * | 2005-12-02 | 2012-10-31 | Gic创新公司 | 具有快速释放的厚朴提取物的咀嚼性组合物 |
| AU2006320846B2 (en) * | 2005-12-02 | 2010-08-19 | Gic Innovations Company | Vehicles for oral care with Magnolia Bark Extract |
| EP1971312A1 (en) * | 2005-12-06 | 2008-09-24 | MonoSol Rx LLC | Topical film compositions for delivery of actives |
| US20070148213A1 (en) * | 2005-12-22 | 2007-06-28 | Sayed Ibrahim | Film containing compositions |
| SE530184C2 (sv) * | 2005-12-23 | 2008-03-18 | Kjell Stenberg | Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater |
| CA2631431A1 (en) * | 2005-12-27 | 2007-07-05 | Monosol Rx, Llc | Ph modulated films for delivery of actives |
| WO2007078874A2 (en) * | 2005-12-30 | 2007-07-12 | Cogentus Pharmaceuticals, Inc. | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| AU2007207563A1 (en) * | 2006-01-20 | 2007-07-26 | Monosol Rx, Llc | Film lined packaging and method of making same |
| JP4668798B2 (ja) * | 2006-01-25 | 2011-04-13 | 株式会社ツキオカ | 水溶性洗浄用フィルム |
| CA2640243C (en) * | 2006-02-17 | 2015-08-18 | Novartis Ag | Disintegrable oral films |
| RU2437657C2 (ru) * | 2006-03-16 | 2011-12-27 | Новартис Аг | Твердая лекарственная форма, содержащая активный агент с маскированным вкусом |
| US20070231387A1 (en) * | 2006-04-04 | 2007-10-04 | Luigi Levi | Film-coated solid dosage forms |
| EP2007362B1 (en) | 2006-04-04 | 2018-09-05 | KG Acquisition LLC | Oral dosage forms including an antiplatelet agent and an acid inhibitor |
| US20090022340A1 (en) * | 2006-04-25 | 2009-01-22 | Kronos Advanced Technologies, Inc. | Method of Acoustic Wave Generation |
| IL175338A0 (en) * | 2006-05-01 | 2006-09-05 | Biota Ltd | Orally administrable films and preparation thereof |
| MX2008014870A (es) | 2006-05-30 | 2009-02-12 | Intarcia Therapeutics Inc | Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas. |
| US20080152761A1 (en) * | 2006-12-20 | 2008-06-26 | Shiji Shen | Packaging of Food Products with Pullulan Films |
| DK2054031T3 (en) | 2006-07-21 | 2016-05-17 | Biodelivery Sciences Int Inc | Transmucosal delivery devices with improved uptake |
| US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
| EP3421031A1 (en) | 2006-08-09 | 2019-01-02 | Intarcia Therapeutics, Inc | Osmotic delivery systems and piston assemblies |
| CA2660565C (en) * | 2006-08-14 | 2012-10-09 | Neurohealing Pharmaceuticals, Inc. | Modafinil-based treatment for premature ejaculation |
| BRPI0621962B1 (pt) * | 2006-08-31 | 2018-05-29 | Kimberly-Clark Worldwide, Inc. | Película respirável tendo uma camada de base, laminado respirável, artigo absorvente e método para formação de uma película respirável |
| CN101516331A (zh) * | 2006-09-20 | 2009-08-26 | 莫诺索尔克斯有限公司 | 含有抗泡沫调味剂的可食用水溶性膜 |
| JP5356235B2 (ja) * | 2006-09-29 | 2013-12-04 | モノソル アールエックス リミテッド ライアビリティ カンパニー | フィルム−埋設包装およびその製造方法 |
| US20080131467A1 (en) * | 2006-11-30 | 2008-06-05 | Dennis Nelson | Film-coated solid dosage form |
| AU2008206362A1 (en) * | 2007-01-12 | 2008-07-24 | Monosol Rx Llc | High dose film compositions and methods of preparation |
| US20100028447A1 (en) | 2007-01-22 | 2010-02-04 | Targacept, Inc. | Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs |
| ZA200905697B (en) * | 2007-02-15 | 2010-10-27 | Derma Young Ltd | Compositions and methods for enhancing transmucosal delivery |
| US20080220029A1 (en) * | 2007-03-05 | 2008-09-11 | Charlene Ng | Fast-dissolving/disintegrating film preparation having high proportion of active |
| US8663659B2 (en) | 2007-03-07 | 2014-03-04 | Novartis Ag | Orally administrable films |
| US20090011115A1 (en) * | 2007-03-13 | 2009-01-08 | Foss Carter D | Edible Pullulan Films Containing Flavoring |
| US20090087468A1 (en) * | 2007-03-28 | 2009-04-02 | Serena Stephenson | Semi-Rigid Gel Article For Disinfecting A Surface |
| WO2008127902A2 (en) * | 2007-04-12 | 2008-10-23 | Tate & Lyle Ingredients Americas, Inc. | Pullulan film containing sweetener |
| MX2009011123A (es) | 2007-04-23 | 2009-11-02 | Intarcia Therapeutics Inc | Formulaciones de suspensiones de peptidos insulinotropicos y sus usos. |
| US20080292683A1 (en) * | 2007-05-24 | 2008-11-27 | Monosolrx, Llc. | Film shreds and delivery system incorporating same |
| US8765155B2 (en) * | 2007-08-30 | 2014-07-01 | Colgate-Palmolive Company | Oral care strip or tape and methods of use and manufacture thereof |
| US9271524B1 (en) | 2007-09-07 | 2016-03-01 | U.S. Smokeless Tobacco Company | Tobacco having reduced tobacco specific nitrosamine content |
| US20090098192A1 (en) * | 2007-10-11 | 2009-04-16 | Fuisz Richard C | Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same |
| US9125434B2 (en) * | 2007-10-11 | 2015-09-08 | Philip Morris Products S.A. | Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet |
| CN107048483A (zh) | 2007-10-11 | 2017-08-18 | 菲利普莫里斯生产公司 | 无烟烟草产品 |
| WO2009058557A2 (en) | 2007-10-12 | 2009-05-07 | Euthanix Corp. | Method and apparatus for euthanizing animals |
| US8298583B2 (en) | 2007-10-19 | 2012-10-30 | Monosol Rx, Llc | Film delivery system for tetrahydrolipstatin |
| US20090142452A1 (en) * | 2007-11-19 | 2009-06-04 | Michael David Campbell | Dissolvable Orally Consumable Flavored Sensual Enhancement Films |
| WO2009073190A1 (en) * | 2007-12-04 | 2009-06-11 | Swedish Match North America, Inc. | Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine |
| US8227658B2 (en) | 2007-12-14 | 2012-07-24 | Kimberly-Clark Worldwide, Inc | Film formed from a blend of biodegradable aliphatic-aromatic copolyesters |
| WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
| AU2009214193A1 (en) * | 2008-02-13 | 2009-08-20 | Bayer Intellectual Property Gmbh | Estradiol-containing drug delivery system |
| EP2252261A2 (en) * | 2008-02-13 | 2010-11-24 | Bayer Schering Pharma Aktiengesellschaft | Drug delivery system with stabilising effect |
| US7998888B2 (en) * | 2008-03-28 | 2011-08-16 | Kimberly-Clark Worldwide, Inc. | Thermoplastic starch for use in melt-extruded substrates |
| US9265779B2 (en) | 2008-05-13 | 2016-02-23 | Lts Lohmann Therapie-Systeme Ag | Method of using a film-shaped preparation comprising oily substances for oral administration |
| DE102008023345B4 (de) | 2008-05-13 | 2014-12-04 | Lts Lohmann Therapie-Systeme Ag | Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung |
| US8338508B2 (en) * | 2008-05-14 | 2012-12-25 | Kimberly-Clark Worldwide, Inc. | Water-sensitive film containing an olefinic elastomer |
| US8147965B2 (en) * | 2008-05-14 | 2012-04-03 | Kimberly-Clark Worldwide, Inc. | Water-sensitive film containing thermoplastic polyurethane |
| MX2010013118A (es) | 2008-06-04 | 2011-03-29 | Colgate Palmolive Co | Implemento de cuidado oral con sistema de cavitacion. |
| AU2009271271A1 (en) * | 2008-06-23 | 2010-01-21 | Biodelivery Sciences International, Inc. | Multidirectional mucosal delivery devices and methods of use |
| US8188185B2 (en) * | 2008-06-30 | 2012-05-29 | Kimberly-Clark Worldwide, Inc. | Biodegradable packaging film |
| US8759279B2 (en) * | 2008-06-30 | 2014-06-24 | Kimberly-Clark Worldwide, Inc. | Fragranced biodegradable film |
| US8927617B2 (en) | 2008-06-30 | 2015-01-06 | Kimberly-Clark Worldwide, Inc. | Fragranced water-sensitive film |
| US20110305768A1 (en) * | 2008-07-01 | 2011-12-15 | The Johns Hopkins University | Quick-dissolving oral thin film for targeted delivery of therapeutic agents |
| FR2933959B1 (fr) * | 2008-07-16 | 2010-09-10 | Roquette Freres | Procede de fabrication de films directement en alveole. |
| US20100040727A1 (en) * | 2008-08-18 | 2010-02-18 | Monosol Rx, Llc | Method for Improving Uniformity of Content in Edible Film Manufacturing |
| US8282954B2 (en) * | 2008-12-15 | 2012-10-09 | Monosol Rx, Llc | Method for manufacturing edible film |
| US8329601B2 (en) | 2008-12-18 | 2012-12-11 | Kimberly-Clark Worldwide, Inc. | Biodegradable and renewable film |
| US8283006B2 (en) * | 2008-12-18 | 2012-10-09 | Kimberly-Clark Worldwide, Inc. | Injection molding material containing starch and plant protein |
| US8784879B2 (en) | 2009-01-14 | 2014-07-22 | Corium International, Inc. | Transdermal administration of tamsulosin |
| US20100183717A1 (en) | 2009-01-16 | 2010-07-22 | Kristin Arnold | Controlled-release formulations |
| WO2010090876A2 (en) * | 2009-01-21 | 2010-08-12 | University Of Florida Research Foundation, Inc. | Satiation peptide administration |
| JP5674480B2 (ja) * | 2009-01-29 | 2015-02-25 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
| WO2010086989A1 (ja) * | 2009-01-29 | 2010-08-05 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
| BRPI1013223A2 (pt) | 2009-03-04 | 2017-09-26 | Regenera Pharma Ltd | usos terapêuticos de frações de goma de mástique |
| TR201911270T4 (tr) | 2009-03-04 | 2019-08-21 | Regenera Pharma Ltd | Polimerik mirsen bileşimleri. |
| US20100256215A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Menthol-Melatonin Dissolving Film |
| US20100256197A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Nicotine Dissolving Film With Or Without Menthol |
| US20100285130A1 (en) * | 2009-05-06 | 2010-11-11 | Monosol Rx, Llc | Coating of complexed actives in film formulations |
| US20100297232A1 (en) * | 2009-05-19 | 2010-11-25 | Monosol Rx, Llc | Ondansetron film compositions |
| MY160387A (en) | 2009-05-26 | 2017-03-15 | Colgate Palmolive Co | Dentifrice composition |
| TWI396554B (zh) * | 2009-05-26 | 2013-05-21 | Colgate Palmolive Co | 增進可溶性鋅的量之口腔保健調配物 |
| CN105411869A (zh) | 2009-05-26 | 2016-03-23 | 高露洁-棕榄公司 | 洁齿剂组合物 |
| PL2952191T3 (pl) | 2009-06-12 | 2019-02-28 | Sunovion Pharmaceuticals Inc. | Apomorfina w postaci do podawania podjęzykowego |
| CA2767950C (en) | 2009-07-27 | 2019-11-12 | Suresensors Ltd | Improvements relating to sensor devices |
| CA2769636A1 (en) * | 2009-07-30 | 2011-02-03 | The Procter & Gamble Company | Oral care articles and methods |
| US8475832B2 (en) * | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
| NZ598686A (en) | 2009-09-28 | 2014-05-30 | Intarcia Therapeutics Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
| CA2779025A1 (en) | 2009-10-28 | 2011-05-05 | Regenera Pharma Ltd. | Therapeutic uses of oligomeric and polymeric monoterpenes |
| US8701671B2 (en) | 2011-02-04 | 2014-04-22 | Joseph E. Kovarik | Non-surgical method and system for reducing snoring |
| US9549842B2 (en) | 2011-02-04 | 2017-01-24 | Joseph E. Kovarik | Buccal bioadhesive strip and method of treating snoring and sleep apnea |
| RU2554807C2 (ru) * | 2009-12-04 | 2015-06-27 | Колгейт-Палмолив Компани | Растворимые пленки, содержащие высокие концентрации неионных поверхностно-активных веществ, таких как полисорбаты, для увеличения высоких нагрузок твердых продуктов |
| US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
| US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
| CA2783877A1 (en) * | 2009-12-10 | 2011-06-16 | A. Mark Schobel | Ph sensitive compounds in taste masking within oral thin film strips |
| CA2785639A1 (en) | 2009-12-30 | 2011-07-07 | Novartis Ag | Melt extruded nicotine thin strips |
| WO2011081625A1 (en) | 2009-12-30 | 2011-07-07 | Novartis Ag | Melt extruded thin strips containing coated pharmaceutical actives |
| AR079890A1 (es) * | 2010-01-13 | 2012-02-29 | Colgate Palmolive Co | Estabilizacion de peliculas de oxido de zinc en composiciones bucales |
| TWI435733B (zh) | 2010-01-29 | 2014-05-01 | Colgate Palmolive Co | 用於口臭控制之口腔保健調配物 |
| JP5751868B2 (ja) | 2010-03-30 | 2015-07-22 | 日東電工株式会社 | フィルム状製剤及びその製造方法 |
| US20110276522A1 (en) * | 2010-03-31 | 2011-11-10 | Kehoe Gary S | Standardization and reconstitution of phytochemicals for medical dispensation |
| US20110263606A1 (en) * | 2010-04-26 | 2011-10-27 | Horst Zerbe | Solid oral dosage forms comprising tadalafil |
| US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
| US20110269841A1 (en) * | 2010-05-03 | 2011-11-03 | Innoteq, Inc. | Thin film with methadone active ingredient |
| US20110269844A1 (en) * | 2010-05-03 | 2011-11-03 | Innoteq, Inc. | Thin film with propofol active ingredient |
| US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
| WO2011156711A1 (en) | 2010-06-10 | 2011-12-15 | Schobel Alexander M | Nanoparticle film delivery systems |
| BR112012030046A2 (pt) | 2010-06-30 | 2016-08-09 | Colgate Palmolive Co | películas de camada múltipla para a liberação de aroma |
| KR101875984B1 (ko) | 2010-09-07 | 2018-07-06 | 레제네라 파마 리미티드 | 매스틱 검의 산성 추출물을 포함하는 조성물 |
| DE102010048408A1 (de) | 2010-10-15 | 2012-04-19 | Lts Lohmann Therapie-Systeme Ag | Laminat mit verbessertem Wasserretentionsverhalten |
| US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
| US10238684B2 (en) | 2010-11-18 | 2019-03-26 | Foundational Biosystems, Llc | Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same |
| CN103228250B (zh) | 2010-12-07 | 2016-01-20 | 高露洁-棕榄公司 | 包含含锌薄膜的口腔和个人护理组合物 |
| EP3735988A1 (en) | 2010-12-16 | 2020-11-11 | Sunovion Pharmaceuticals Inc. | Sublingual films |
| US12257272B2 (en) | 2015-12-24 | 2025-03-25 | Seed Health, Inc. | Method and system for reducing the likelihood of developing depression in an individual |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US12279989B2 (en) | 2011-02-04 | 2025-04-22 | Seed Health, Inc. | Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity |
| US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US11129799B2 (en) * | 2011-04-12 | 2021-09-28 | Aquestive Therapeutics, Inc. | Dual lane coating |
| EP2701668A1 (en) | 2011-04-29 | 2014-03-05 | Massachusetts Institute of Technology | Layer processing for pharmaceuticals |
| US8241661B1 (en) * | 2011-06-24 | 2012-08-14 | Fuisz Richard C | Biocompatible film with variable cross-sectional properties |
| KR101303479B1 (ko) * | 2011-07-28 | 2013-09-06 | (주)씨엘팜 | 가식성 필름형성 조성물 및 약물이 함유된 가식성 필름형 제제 |
| EA201991223A1 (ru) | 2011-08-18 | 2019-10-31 | Не вызывающие зависимость мукоадгезивные устройства для доставки бупренорфина | |
| US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
| US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
| WO2013114153A2 (en) | 2011-12-14 | 2013-08-08 | Lts Lohmann Therapie-Systeme Ag | Wafer and capsule formulations with enhanced dissolution rates for fenofibrate |
| US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
| JP5841433B2 (ja) | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
| US10806703B2 (en) | 2012-01-20 | 2020-10-20 | Lts Lohmann Therapie-System Ag | Transmucosal administration system for a pharmaceutical drug |
| US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| FR2990349B1 (fr) | 2012-05-11 | 2014-08-08 | Pf Medicament | Film monocouche a desintegration rapide et son utilisation dans l'hygiene buccale |
| JP6050031B2 (ja) * | 2012-06-01 | 2016-12-21 | 森下仁丹株式会社 | フィルム製剤 |
| RU2510558C1 (ru) * | 2012-07-19 | 2014-03-27 | Александр Викторович Атаманов | Беспроводная зарядная система для маломощных потребителей электрической энергии |
| WO2014018075A1 (en) | 2012-07-23 | 2014-01-30 | Crayola, Llc | Dissolvable films and methods of using the same |
| WO2014078581A1 (en) | 2012-11-14 | 2014-05-22 | Smith & Nephew, Inc. | Stable thermolysin hydrogel |
| US10829621B2 (en) | 2013-01-11 | 2020-11-10 | Monosol, Llc | Edible water-soluble film |
| US20140275194A1 (en) | 2013-03-15 | 2014-09-18 | Monosol Rx, Llc | Films and drug delivery systems for rizatriptan |
| US9303918B2 (en) | 2013-03-15 | 2016-04-05 | Monosol Rx, Llc | Process for drying a wet film with control of loss on drying |
| WO2014145699A1 (en) | 2013-03-15 | 2014-09-18 | New Jersey Institute Of Technology | System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process |
| RU2015137174A (ru) | 2013-03-15 | 2017-04-24 | Смит энд Невью, Инк. | Растворимая образующая гель плёнка и способ очистки раны |
| US9278050B2 (en) | 2013-04-01 | 2016-03-08 | Trevor Anderson | Dissolvable medication administration bag and method of using the same |
| WO2015015303A2 (en) | 2013-07-31 | 2015-02-05 | Intelgenx Corp. | Instantly wettable oral film dosage form without surfactant or polyalcohol |
| US12329783B2 (en) | 2013-12-20 | 2025-06-17 | Seed Health, Inc. | Method and system to improve the health of a person's skin microbiome |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| RU2676288C2 (ru) | 2013-12-31 | 2018-12-27 | Джонсон энд Джонсон Консьюмер Инк. | Способ формирования многослойного формованного пленочного продукта в один проход |
| KR102240525B1 (ko) | 2013-12-31 | 2021-04-16 | 존슨 앤드 존슨 컨수머 인코포레이티드 | 다층의 형상화된 필름을 형성하기 위한 방법 |
| CA2935191C (en) | 2013-12-31 | 2021-11-09 | Johnson & Johnson Consumer Inc. | Process for forming a shaped film product |
| KR20170012210A (ko) | 2014-04-04 | 2017-02-02 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| WO2015179461A1 (en) | 2014-05-20 | 2015-11-26 | Massachusetts Institute Of Technology | Plasticity induced bonding |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| CN106999601A (zh) * | 2014-12-09 | 2017-08-01 | 莫诺索尔克斯有限公司 | 基于直链多糖的膜产品 |
| KR101695071B1 (ko) | 2014-12-26 | 2017-01-11 | 연세대학교 산학협력단 | 액상으로 약물을 분산시킨 필름형태의 약제학적 조성물 |
| EP4578461A3 (en) | 2015-04-21 | 2025-09-03 | Sumitomo Pharma America, Inc. | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa |
| AU2016270984B2 (en) | 2015-06-03 | 2021-02-25 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
| US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
| US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
| EP3397081A4 (en) * | 2015-12-30 | 2019-08-28 | Next Generation Labs, LLC | NICOTRENATE THERAPY PRODUCTS WITH SYNTHETIC NICOTINE |
| KR20240170975A (ko) | 2016-01-26 | 2024-12-05 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| ES2879888T3 (es) | 2016-03-25 | 2021-11-23 | Intra Cellular Therapies Inc | Compuestos orgánicos y su uso en el tratamiento o prevención de trastornos del sistema nervioso central |
| US11311633B2 (en) | 2016-04-16 | 2022-04-26 | University Of Florida Research Foundation, Incorporated | Satiation peptides for weight loss and altered taste sensitivity |
| KR20190005199A (ko) | 2016-05-05 | 2019-01-15 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 강화된 전달 에프네프린 조성물 |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| JP7077237B2 (ja) | 2016-05-16 | 2022-05-30 | インターシア セラピューティクス，インコーポレイティド | グルカゴン受容体選択的ポリペプチド及びその使用方法 |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| EP4454664A3 (en) * | 2016-11-02 | 2025-01-22 | Board of Regents, The University of Texas System | Dissolvable films and methods of their use |
| WO2018126140A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US10906906B2 (en) | 2016-12-29 | 2021-02-02 | Intra-Cellular Therapies, Inc. | Organic compounds |
| MX2019008006A (es) | 2017-01-03 | 2019-08-29 | Intarcia Therapeutics Inc | Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco. |
| IL268970B2 (en) | 2017-03-24 | 2023-12-01 | Intra Cellular Therapies Inc | Oral preparations of heterocyclic gamma carboline derivatives fused for absorption through mucous membranes |
| US10238600B2 (en) | 2017-04-13 | 2019-03-26 | Richard C. Fuisz | Package, system and methods for custody and control of drugs, and method and composition for making an oral soluble film, containing at least one active agent |
| US9901545B1 (en) | 2017-04-13 | 2018-02-27 | Richard C. Fuisz | Method and composition for making an oral soluble film, containing at least one active agent |
| WO2019006010A1 (en) * | 2017-06-27 | 2019-01-03 | The Coca-Cola Company | ORAL SWEETENER COMPOSITIONS AND ASSOCIATED METHODS |
| EP3658110B1 (en) * | 2017-12-20 | 2023-04-05 | Firmenich SA | Oral care compositions |
| MX2020009668A (es) | 2018-03-16 | 2021-01-08 | Intra Cellular Therapies Inc | Métodos novedosos. |
| WO2019183341A1 (en) | 2018-03-23 | 2019-09-26 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US11911492B2 (en) | 2018-05-14 | 2024-02-27 | The Procter & Gamble Company | Oral care compositions comprising metal ions |
| CN112135668B (zh) | 2018-05-14 | 2024-01-02 | 宝洁公司 | 包含金属离子的口腔护理组合物 |
| DK3807260T3 (da) | 2018-06-15 | 2024-10-14 | Reynolds Tobacco Co R | Oprensning af nikotin |
| GB2574878A (en) * | 2018-06-22 | 2019-12-25 | Biofilm Ltd | Oral compositions and mucoadhesive thin films formed therefrom |
| GB2575625A (en) | 2018-06-22 | 2020-01-22 | Church & Dwight Co Inc | Oral care compositions comprising benzocaine and mucoadhesive thin films formed therefrom |
| US12144808B2 (en) | 2018-08-29 | 2024-11-19 | Intra-Cellular Therapies, Inc. | Compositions and methods |
| CA3108553A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| KR20210052472A (ko) | 2018-08-31 | 2021-05-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| US10813889B2 (en) | 2018-09-04 | 2020-10-27 | Babak Ghalili | Cannabinoid and menthol compositions and methods |
| US11235013B2 (en) | 2018-09-04 | 2022-02-01 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
| KR20210078515A (ko) * | 2018-10-18 | 2021-06-28 | 아비어, 인크. | 만성 신장 질환-연관 소양증의 치료 방법 및 장치 |
| JP7388075B2 (ja) * | 2019-02-18 | 2023-11-29 | 富士フイルムビジネスイノベーション株式会社 | 造形装置 |
| CA3136736A1 (en) | 2019-04-25 | 2020-10-29 | The Procter & Gamble Company | Systems and methods for delivering active agents |
| BR112021019723A2 (pt) | 2019-04-25 | 2021-12-14 | Procter & Gamble | Composições para tratamento bucal para liberação de agente ativo |
| EP3958825A1 (en) | 2019-04-25 | 2022-03-02 | The Procter & Gamble Company | Rinseable multi-phase compositions |
| JP2022529190A (ja) | 2019-04-25 | 2022-06-17 | ザ プロクター アンド ギャンブル カンパニー | 活性剤送達のための口腔ケア組成物 |
| CN114072150A (zh) | 2019-07-07 | 2022-02-18 | 细胞内治疗公司 | 新方法 |
| WO2021168696A1 (en) | 2020-02-26 | 2021-09-02 | The Procter & Gamble Company | Oral care compositions for gum health |
| WO2021168684A1 (en) | 2020-02-26 | 2021-09-02 | The Procter & Gamble Company | Oral care compositions for gum health |
| WO2021177937A1 (en) * | 2020-03-02 | 2021-09-10 | Babak Ghalili | Cannabinoid and menthol compositions and methods |
| WO2021177941A1 (en) * | 2020-03-03 | 2021-09-10 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
| DE102020112143B4 (de) | 2020-05-05 | 2022-03-17 | Lts Lohmann Therapie-Systeme Ag | Nicotin - Corona |
| US11173114B1 (en) | 2020-07-10 | 2021-11-16 | Nova Thin Film Pharmaceuticals Llc | Method and system for manufacturing and oral soluble films and oral soluble films made by thereby |
| EP4294368A4 (en) | 2021-02-19 | 2024-11-06 | Nova Thin Film Pharmaceuticals LLC | METHOD AND SYSTEM FOR PRODUCING ORAL SOLUBLE FILMS, ORAL SOLUBLE FILMS COMPOSITIONS, ORAL SOLUBLE FILMS PRODUCED THEREWITH AND METHODS OF USE THEREOF |
| WO2023023884A1 (en) | 2021-08-23 | 2023-03-02 | The Procter & Gamble Company | Oral care compositions for gum health |
| WO2023023886A1 (en) | 2021-08-23 | 2023-03-02 | The Procter & Gamble Company | Oral care compositions for gum health |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
| KR20250033561A (ko) * | 2023-08-31 | 2025-03-10 | 주식회사 케이티앤지 | 니코틴 파우치 및 이의 제조방법 |
| KR20250032618A (ko) * | 2023-08-31 | 2025-03-07 | 주식회사 케이티앤지 | 니코틴 파우치용 포장재, 이를 포함하는 니코틴 파우치, 및 이의 제조방법 |
| KR20250051993A (ko) * | 2023-10-11 | 2025-04-18 | 서울과학기술대학교 산학협력단 | 구강점막용 접착패치 및 이의 제조방법 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2432925A1 (de) * | 1974-07-05 | 1976-01-22 | Schering Ag | Arzneimittelwirkstofftraeger in folienform mit inkorporiertem wirkstoff |
| US4713239A (en) * | 1979-05-29 | 1987-12-15 | Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr | Antianginal film and method of treating ischemic heart disease |
| EP0250187A2 (en) * | 1986-06-16 | 1987-12-23 | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. | Bioadhesive extruded film for intra-oral drug delivery and process |
| EP0259749A1 (de) * | 1986-09-09 | 1988-03-16 | Desitin Arzneimittel GmbH | Darreichungs- und Dosierungsform für Arzneimittelwirkstoffe, Reagentien oder dergleichen sowie Verfahren zu deren Herstellung |
| WO1991005540A1 (de) * | 1989-10-14 | 1991-05-02 | Desitin Arzneimittel Gmbh | Mund- und zahnpflegemittel |
| US5462749A (en) * | 1991-09-25 | 1995-10-31 | Mcnell-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
Family Cites Families (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3931824A (en) * | 1973-09-10 | 1976-01-13 | Celanese Corporation | Smoking materials |
| US4007290A (en) * | 1974-01-09 | 1977-02-08 | General Foods Corporation | Caffeine antagonim |
| US4136145A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| DE2449865B2 (de) * | 1974-10-17 | 1981-06-19 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Folienförmiges Arzneimittel |
| US4136162A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| IN142428B (cs) * | 1974-07-05 | 1977-07-09 | Schering Ag | |
| US4082841A (en) * | 1975-10-10 | 1978-04-04 | Lever Brothers Company | Dentifrice |
| US4029757A (en) * | 1975-12-15 | 1977-06-14 | Hoffmann-La Roche Inc. | Manufacture of pharmaceutical unit dosage forms |
| ZA767136B (en) * | 1975-12-15 | 1977-10-26 | Hoffmann La Roche | Novel dosage form |
| US4031200A (en) * | 1975-12-15 | 1977-06-21 | Hoffmann-La Roche Inc. | Manufacture of pharmaceutical unit dosage forms |
| US4029758A (en) * | 1975-12-15 | 1977-06-14 | Hoffmann-La Roche Inc. | Preparation of pharmaceutical unit dosage forms |
| US4332789A (en) * | 1975-12-15 | 1982-06-01 | Hoffmann-La Roche Inc. | Pharmaceutical unit dosage forms |
| JPS5758615A (en) * | 1980-09-26 | 1982-04-08 | Nippon Soda Co Ltd | Film agnent and its preparation |
| US4486436A (en) * | 1982-07-22 | 1984-12-04 | Analgesic Associates | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
| GB8301659D0 (en) | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
| JPS6130516A (ja) * | 1984-07-20 | 1986-02-12 | Nichiban Co Ltd | 粘膜付着製剤 |
| JPS6185315A (ja) * | 1984-10-04 | 1986-04-30 | Teikoku Seiyaku Kk | シ−ト状製剤 |
| US4900556A (en) | 1985-04-26 | 1990-02-13 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
| EP0200508B1 (en) * | 1985-04-27 | 1991-10-02 | Nitto Denko Corporation | Adhesive oral bandages and oral pharmaceutical preparations |
| US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
| US5783207A (en) | 1985-05-01 | 1998-07-21 | University Of Utah Research Foundation | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine |
| US5785989A (en) * | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
| JPS61280423A (ja) * | 1985-06-05 | 1986-12-11 | Kiyuukiyuu Yakuhin Kogyo Kk | 口腔内粘膜貼付剤 |
| DE3676626D1 (de) * | 1985-10-09 | 1991-02-07 | Desitin Arzneimittel Gmbh | Verfahren zur herstellung einer darreichungs- und dosierungsform fuer arzneimittel-wirkstoffe, reagentien oder andere wirkstoffe. |
| US5229164A (en) * | 1985-12-19 | 1993-07-20 | Capsoid Pharma Gmbh | Process for producing individually dosed administration forms |
| JPH0729915B2 (ja) * | 1986-02-01 | 1995-04-05 | 帝國製薬株式会社 | シ−ト状口腔内貼付剤 |
| US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| US5032387A (en) * | 1986-11-06 | 1991-07-16 | Princeton Pharmaceutical Inc. | Dental and oral hygiene preparations |
| GB8630273D0 (en) * | 1986-12-18 | 1987-01-28 | Til Medical Ltd | Pharmaceutical delivery systems |
| US4855142A (en) * | 1987-02-27 | 1989-08-08 | Ciba-Geigy Corporation | Pharmaceutical plaster |
| US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5234957A (en) * | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| US4900552A (en) * | 1988-03-30 | 1990-02-13 | Watson Laboratories, Inc. | Mucoadhesive buccal dosage forms |
| US5047244A (en) * | 1988-06-03 | 1991-09-10 | Watson Laboratories, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
| DE3827561C1 (cs) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| JP2656338B2 (ja) * | 1989-01-31 | 1997-09-24 | 日東電工株式会社 | 口腔粘膜貼付製剤 |
| JPH02258718A (ja) * | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
| US5824334A (en) * | 1989-09-05 | 1998-10-20 | University Of Utah Research Foundation | Tobacco substitute |
| US5354551A (en) * | 1989-10-14 | 1994-10-11 | Desitin Arzneimittel Gmbh | Oral and dental hygiene preparation |
| US5525351A (en) * | 1989-11-07 | 1996-06-11 | Dam; Anders | Nicotine containing stimulant unit |
| JPH03209327A (ja) * | 1990-01-11 | 1991-09-12 | Teikoku Seiyaku Kk | ニコチン含有口腔粘膜貼付剤 |
| GB9009390D0 (en) | 1990-04-26 | 1990-06-20 | Smith Kline French Lab | Pharmaceutical compositions |
| US5147854A (en) * | 1990-05-22 | 1992-09-15 | Hoffmann-La Roche Inc. | Tgf-b compositions and method |
| DE4018247A1 (de) * | 1990-06-07 | 1991-12-12 | Lohmann Therapie Syst Lts | Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen |
| US5147654A (en) | 1990-07-23 | 1992-09-15 | Alza Corporation | Oral osmotic device for delivering nicotine |
| ATE111351T1 (de) * | 1990-07-23 | 1994-09-15 | Alza Corp | Oral anzuwendende osmotische vorrichtung zur abgabe von nicotin. |
| US5686094A (en) * | 1991-04-01 | 1997-11-11 | Theratech, Inc. | Controlled release formulations for the treatment of xerostomia |
| EP0554297B1 (en) * | 1990-10-25 | 1995-04-12 | The Boots Company PLC | Mouthwash |
| SE466134B (sv) * | 1990-11-22 | 1992-01-07 | Kabi Pharmacia Ab | Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner |
| IT1250421B (it) * | 1991-05-30 | 1995-04-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive. |
| JPH05236885A (ja) | 1991-07-17 | 1993-09-17 | Tazawa Toshihiko | フィルム化した芳香清涼食品 |
| JPH0541602A (ja) | 1991-08-06 | 1993-02-19 | Fujitsu General Ltd | 円偏波及び直線偏波共用一次放射器 |
| JP2671248B2 (ja) * | 1991-10-23 | 1997-10-29 | ブロック・ドラッグ・カンパニー・インコーポレイテッド | 薬効または化粧効果成分の浸透性増進方法 |
| US5414005A (en) * | 1993-10-28 | 1995-05-09 | Dynagen, Inc. | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation |
| DK0641192T3 (da) * | 1992-05-18 | 1998-03-02 | Minnesota Mining & Mfg | Anordning til transmucosal lægemiddelafgivelse |
| US5346701A (en) * | 1993-02-22 | 1994-09-13 | Theratech, Inc. | Transmucosal delivery of macromolecular drugs |
| US5565466A (en) | 1993-08-13 | 1996-10-15 | Zonagen, Inc. | Methods for modulating the human sexual response |
| WO1995005416A2 (en) * | 1993-08-19 | 1995-02-23 | Cygnus Therapeutic Systems | Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
| WO1995018046A1 (en) | 1993-12-28 | 1995-07-06 | Frank Richard D | Pakaging and dispensing device for sterile articles |
| AU676430B2 (en) | 1994-03-07 | 1997-03-06 | Theratech, Inc. | Drug-containing adhesive composite transdermal delivery device |
| JPH09503023A (ja) | 1994-06-16 | 1997-03-25 | フアルマシア・エツセ・ピー・アー | 生物付着性澱粉及び該澱粉の製造方法 |
| AU2703795A (en) | 1994-06-23 | 1996-01-19 | Procter & Gamble Company, The | Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine |
| US6436407B1 (en) * | 1994-08-26 | 2002-08-20 | The Administrators Of The Tulane Educational Fund | Mutant enterotoxin effective as a non-toxic adjuvant |
| WO1996025910A1 (en) * | 1995-02-23 | 1996-08-29 | Cygnus, Inc. | Water-soluble pressure-sensitive mucoadhesive |
| FR2733684B1 (fr) * | 1995-05-03 | 1997-05-30 | Cird Galderma | Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique |
| JP2791317B2 (ja) | 1995-12-26 | 1998-08-27 | 株式会社三和化学研究所 | 多層フィルム製剤 |
| FR2742989B1 (fr) * | 1995-12-29 | 1998-01-23 | Adir | Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs |
| DE19615820A1 (de) * | 1996-04-06 | 1997-10-09 | Holger Specht | Zahnpflegemittel und Verfahren zu seiner Herstellung |
| US5955098A (en) | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
| US5955096A (en) * | 1996-06-25 | 1999-09-21 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients |
| US5853740A (en) * | 1996-08-07 | 1998-12-29 | Abbott Laboratories | Delivery system for pharmaceutical agents encapsulated with oils |
| US5871905A (en) * | 1996-09-04 | 1999-02-16 | Epitope, Inc. | Reduction of false positives in oral-fluid based immunoassays |
| DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| JP3460538B2 (ja) | 1997-10-08 | 2003-10-27 | 救急薬品工業株式会社 | 速溶性フィルム製剤 |
| DE19837073A1 (de) | 1998-08-17 | 2000-03-23 | Lohmann Therapie Syst Lts | Folienförmige Wirkstoffträger |
| US6165512A (en) * | 1998-10-30 | 2000-12-26 | Fuisz Technologies Ltd. | Dosage forms containing taste masked active agents |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| US6342496B1 (en) * | 1999-03-01 | 2002-01-29 | Sepracor Inc. | Bupropion metabolites and methods of use |
| US6489341B1 (en) * | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
| US6335023B1 (en) * | 1999-06-30 | 2002-01-01 | Ruey J. Yu | Oligosaccharide aldonic acids and their topical use |
| DE19932603A1 (de) | 1999-07-13 | 2001-01-25 | Gruenenthal Gmbh | Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren |
| KR100605666B1 (ko) | 1999-07-22 | 2006-07-28 | 워너-램버트 캄파니 엘엘씨 | 풀루란 필름 조성물 |
| US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| JP4044709B2 (ja) | 1999-11-19 | 2008-02-06 | 信越化学工業株式会社 | 水系フィルムコーティング剤及び経口固形製剤 |
| DE10032456A1 (de) | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
| DE10107659B4 (de) | 2001-02-19 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin |
| EP1389910A4 (en) | 2001-04-20 | 2005-11-02 | Lavipharm Lab Inc | INTRABUCAL DISTRIBUTION OF NICOTINE INTENDED TO STOP SMOKING |
| JP4267926B2 (ja) | 2001-04-24 | 2009-05-27 | リンテック株式会社 | 経口投与剤及び経口投与剤保持体 |
| WO2003003957A1 (en) * | 2001-07-06 | 2003-01-16 | Lavipharm Laboratories Inc. | Quick dissolving oral mucosal drug delivery device with moisture barrier coating |
| US6585997B2 (en) | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| JP5089840B2 (ja) | 2001-09-25 | 2012-12-05 | 救急薬品工業株式会社 | ニコチン含有フィルム製剤 |
| EP1458367B2 (en) | 2001-10-12 | 2021-01-27 | Aquestive Therapeutics, Inc. | Uniform films for rapidly dissolving dosage form incorporating taste-masking compositions |
-
1996
- 1996-11-11 DE DE19646392A patent/DE19646392A1/de not_active Withdrawn
-
1997
- 1997-08-01 US US08/904,607 patent/US5948430A/en not_active Expired - Lifetime
- 1997-10-21 TW TW092105140A patent/TWI250029B/zh not_active IP Right Cessation
- 1997-10-21 TW TW086115552A patent/TW533083B/zh not_active IP Right Cessation
- 1997-10-22 PL PL97333677A patent/PL190376B1/pl unknown
- 1997-10-22 AU AU48682/97A patent/AU739698B2/en not_active Ceased
- 1997-10-22 DE DE59712993T patent/DE59712993D1/de not_active Expired - Lifetime
- 1997-10-22 ES ES03014213T patent/ES2322699T3/es not_active Expired - Lifetime
- 1997-10-22 ID IDW990297A patent/ID22526A/id unknown
- 1997-10-22 IL IL12981997A patent/IL129819A0/xx not_active IP Right Cessation
- 1997-10-22 TR TR1999/01633T patent/TR199901633T2/xx unknown
- 1997-10-22 CZ CZ0164799A patent/CZ297354B6/cs not_active IP Right Cessation
- 1997-10-22 JP JP52208898A patent/JP4063331B2/ja not_active Expired - Lifetime
- 1997-10-22 DE DE59710670T patent/DE59710670D1/de not_active Expired - Lifetime
- 1997-10-22 ES ES97911237T patent/ES2206692T3/es not_active Expired - Lifetime
- 1997-10-22 HU HU0500666A patent/HU230022B1/hu unknown
- 1997-10-22 DK DK03014213T patent/DK1362584T3/da active
- 1997-10-22 SK SK622-99A patent/SK285100B6/sk not_active IP Right Cessation
- 1997-10-22 AT AT03014213T patent/ATE422157T1/de active
- 1997-10-22 HU HU9904207A patent/HU228464B1/hu not_active IP Right Cessation
- 1997-10-22 KR KR1019997004145A patent/KR100604995B1/ko not_active Expired - Fee Related
- 1997-10-22 DE DE29724755U patent/DE29724755U1/de not_active Expired - Lifetime
- 1997-10-22 CA CA002265651A patent/CA2265651C/en not_active Expired - Lifetime
- 1997-10-22 KR KR1020057014063A patent/KR100569847B1/ko not_active Expired - Fee Related
- 1997-10-22 NZ NZ335063A patent/NZ335063A/xx not_active IP Right Cessation
- 1997-10-22 AT AT97911237T patent/ATE247954T1/de active
- 1997-10-22 DK DK97911237T patent/DK0936905T3/da active
- 1997-10-22 SK SK5041-2005A patent/SK285999B6/sk not_active IP Right Cessation
- 1997-10-22 EP EP97911237A patent/EP0936905B1/de not_active Expired - Lifetime
- 1997-10-22 WO PCT/EP1997/005820 patent/WO1998020862A1/de active IP Right Grant
- 1997-10-22 SI SI9730590T patent/SI0936905T1/xx unknown
- 1997-10-22 PT PT97911237T patent/PT936905E/pt unknown
- 1997-10-22 PT PT03014213T patent/PT1362584E/pt unknown
- 1997-10-22 EP EP03014213A patent/EP1362584B1/de not_active Expired - Lifetime
- 1997-11-10 ZA ZA9710093A patent/ZA9710093B/xx unknown
- 1997-11-10 MY MYPI97005325A patent/MY125548A/en unknown
-
1999
- 1999-04-06 US US09/287,181 patent/US6177096B1/en not_active Expired - Lifetime
- 1999-04-22 NO NO19991921A patent/NO325073B1/no not_active IP Right Cessation
-
2000
- 2000-08-02 US US09/630,562 patent/US6284264B1/en not_active Expired - Lifetime
-
2001
- 2001-08-13 US US09/927,327 patent/US20010046511A1/en not_active Abandoned
-
2002
- 2002-05-14 US US10/143,962 patent/US6709671B2/en not_active Expired - Lifetime
- 2002-06-05 US US10/161,670 patent/US6592887B2/en not_active Expired - Lifetime
-
2004
- 2004-02-05 US US10/771,388 patent/US8865202B2/en not_active Expired - Fee Related
-
2005
- 2005-06-01 JP JP2005161714A patent/JP4817721B2/ja not_active Expired - Fee Related
- 2005-07-06 NO NO20053307A patent/NO20053307D0/no not_active Application Discontinuation
- 2005-07-31 IL IL169984A patent/IL169984A/en not_active IP Right Cessation
-
2009
- 2009-09-28 JP JP2009222637A patent/JP2010006832A/ja active Pending
-
2011
- 2011-11-09 US US13/292,590 patent/US20120114705A1/en not_active Abandoned
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2432925A1 (de) * | 1974-07-05 | 1976-01-22 | Schering Ag | Arzneimittelwirkstofftraeger in folienform mit inkorporiertem wirkstoff |
| US4713239A (en) * | 1979-05-29 | 1987-12-15 | Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr | Antianginal film and method of treating ischemic heart disease |
| EP0250187A2 (en) * | 1986-06-16 | 1987-12-23 | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. | Bioadhesive extruded film for intra-oral drug delivery and process |
| EP0259749A1 (de) * | 1986-09-09 | 1988-03-16 | Desitin Arzneimittel GmbH | Darreichungs- und Dosierungsform für Arzneimittelwirkstoffe, Reagentien oder dergleichen sowie Verfahren zu deren Herstellung |
| WO1991005540A1 (de) * | 1989-10-14 | 1991-05-02 | Desitin Arzneimittel Gmbh | Mund- und zahnpflegemittel |
| US5462749A (en) * | 1991-09-25 | 1995-10-31 | Mcnell-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ297354B6 (cs) | Prípravek pro aplikaci v ústní dutine s filmem nebo fólií s okamzitou smácitelností | |
| US9937123B2 (en) | Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents | |
| HK1035316B (en) | Immediate wettability water soluble film or water soluble layer for oral application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD00 | Pending as of 2000-06-30 in czech republic | ||
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20161022 |